YAMAMOTO RESEARCH - MICROCIRCOLO
Food supplement declared in France, declaration No 2019-9-673, decision dated 25 September 2019
YAMAMOTO RESEARCH - MICROCIRCOLO is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- YAMAMOTO S.P.A.
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Comprimé
- Daily dose
- 2 comprimés
- Directions for use
- prendre 2 comprimés par jour avec de l’eau.
Declaration 165624, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Centella asiatica (L.) Urb. | Parties aériennes | Extrait sec alcoolique | 50 mg |
| Vaccinium myrtillus L. | Feuille (bourgeon) | Extrait sec hydroalcoolique | 25 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Diosmine | not declared |
| Troxérutine | not declared |
| Bromélaïne | not declared |
| Hespéridine | not declared |
Additives
E460, E341, E464, E468, E551, E470b, E172
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas être utilisés comme substituts d'un régime alimentaire varié. Une alimentation variée et équilibrée et un mode de vie sain sont importants. Tenir hors de la portée des jeunes enfants. Conserver dans un endroit frais et sec. Évitez l'exposition aux sources de chaleur et à la lumière du soleil.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.